03759 PHARMARON
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.80X | Oper Margin | 20.0% |
|---|---|---|---|
| LT Debt/Equity | 35.1% | Net Margin | 14.6% |
| Total Debt/Equity | 43.9% | Return on Equity | 13.2% |
| Price/Book | 2.20X | Return on Assets | 7.5% |
| (HKD 17.980) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 1,907.23 | 1,764.73 | 1,540.64 | 2,031.20 | 1,390.68 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +8.1 | +14.5 | -24.2 | +46.1 | +127.4 |
| Earnings Per Share (HKD) | 1.078 | 0.996 | 0.869 | 1.141 | 0.782 |
| Earnings Per Share Growth (%) | +8.2 | +14.6 | -23.8 | +45.9 | +90.0 |
| Dividend Per Share (HKD) | 0.219 | 0.220 | 0.219 | 0.235 | 0.161 |
| P/E* (X) | 16.68 | 18.06 | 20.69 | 15.76 | 22.99 |
| Yield (%) | 1.22 | 1.22 | 1.22 | 1.31 | 0.90 |
| Dividend Share (%) | 20.30 | 22.08 | 25.22 | 20.58 | 20.60 |
| Book NAV (HKD) | 8.178 | 7.746 | 6.620 | 6.934 | 5.890 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 3,099 | 2,671 | +16.0 | 2,724 |
| Operating Result | 386.384 | 281.103 | +37.5 | 414.687 |
| Associates | -22.797 | -12.484 | +82.6 | 11.915 |
| Profit Before Taxation | 363.587 | 268.619 | +35.4 | 426.602 |
| Taxation | 83.932 | 52.699 | +59.3 | 76.454 |
| Profit /( Loss) After Taxation | 279.655 | 215.92 | +29.5 | 350.148 |
| Minority Interests | -25.92 | -14.638 | +77.1 | 1.893 |
| Net Profit | 305.575 | 230.558 | +32.5 | 348.255 |
| Earnings Per Share () | 0.1862 | 0.1408 | +32.2 | 0.2249 |
| Announcement Date | 2025-04-27 | 2024-04-25 | NA | 2023-04-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
